
dNovo
dNovo is a YC Summer 2018 (S18) company. Based in San Jose, CA, USA. Team of 4.
About dNovo
Summary
dNovo develops a cellular reprogramming technology to generate new hair stem cells, targeting patients with hair loss caused by male-pattern baldness or age-related hair miniaturization. A small sample of a patient's skin or blood is converted into personalized hair stem cells that replace those lost, producing new hair rather than slowing its loss. Beyond hair, dNovo aims to apply the same platform to regenerate other cell types, tissues, and organs lost to aging.
From the Y Combinator listing
The cure for hair loss.
At dNovo, we are curing hair loss by creating new hair, de novo. We are doing this with cellular reprogramming technology that we pioneered at Stanford and Harvard. With this technology, we can take any patient derived cell, whether it be blood, skin or fat and reprogram (convert) them into medically relevant cell types. Our first objective is to cure hair loss by using our reprogramming technology to make new hair (patent pending). This is different from everything currently available on the market because the hair loss industry is focused on maintaining the hair that you already have, but no one is trying to produce NEW hair, de novo. After hair, we envision using our cellular reprogramming technique to make any cell, any tissue or any organ on demand to replace what is lost as we age.
Facts
- Healthcare / Healthcare -> Therapeutics
- San Jose, CA, USA
- 4
- Inactive
- Early
Founders (1)
- Ernesto Lujan
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works